Naples Global Advisors LLC Has $1.68 Million Stock Holdings in Cardinal Health, Inc. $CAH

Naples Global Advisors LLC lessened its stake in shares of Cardinal Health, Inc. (NYSE:CAH) by 2.0% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 9,985 shares of the company’s stock after selling 200 shares during the period. Naples Global Advisors LLC’s holdings in Cardinal Health were worth $1,677,000 as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of the business. MassMutual Private Wealth & Trust FSB boosted its position in shares of Cardinal Health by 3.6% in the second quarter. MassMutual Private Wealth & Trust FSB now owns 1,767 shares of the company’s stock valued at $297,000 after acquiring an additional 62 shares during the period. Perigon Wealth Management LLC boosted its position in shares of Cardinal Health by 3.2% in the second quarter. Perigon Wealth Management LLC now owns 2,314 shares of the company’s stock valued at $389,000 after acquiring an additional 72 shares during the period. Community Bank & Trust Waco Texas boosted its position in shares of Cardinal Health by 1.3% in the second quarter. Community Bank & Trust Waco Texas now owns 5,598 shares of the company’s stock valued at $940,000 after acquiring an additional 74 shares during the period. Pinnacle Bancorp Inc. boosted its position in shares of Cardinal Health by 11.2% in the first quarter. Pinnacle Bancorp Inc. now owns 767 shares of the company’s stock valued at $106,000 after acquiring an additional 77 shares during the period. Finally, G&S Capital LLC boosted its position in shares of Cardinal Health by 0.8% in the second quarter. G&S Capital LLC now owns 9,476 shares of the company’s stock valued at $1,592,000 after acquiring an additional 78 shares during the period. 87.17% of the stock is owned by institutional investors.

Insider Activity at Cardinal Health

In other Cardinal Health news, insider Jessica L. Mayer sold 38,078 shares of Cardinal Health stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total transaction of $5,666,767.96. Following the completion of the transaction, the insider directly owned 48,457 shares of the company’s stock, valued at approximately $7,211,370.74. This trade represents a 44.00% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Michelle D. Greene sold 13,500 shares of Cardinal Health stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total value of $2,009,070.00. Following the transaction, the insider directly owned 14,976 shares of the company’s stock, valued at approximately $2,228,728.32. The trade was a 47.41% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 271,676 shares of company stock valued at $40,489,525. Insiders own 0.12% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on CAH. Morgan Stanley reissued an “overweight” rating on shares of Cardinal Health in a research report on Tuesday, August 12th. Wells Fargo & Company reaffirmed an “overweight” rating and issued a $185.00 target price (up from $183.00) on shares of Cardinal Health in a research report on Wednesday, August 13th. UBS Group reiterated a “buy” rating on shares of Cardinal Health in a research note on Tuesday, August 12th. Evercore ISI decreased their price target on shares of Cardinal Health from $200.00 to $190.00 and set an “outperform” rating on the stock in a research note on Wednesday, August 13th. Finally, Wall Street Zen downgraded shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 2nd. Eleven analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, Cardinal Health has an average rating of “Moderate Buy” and an average target price of $165.93.

Cardinal Health Stock Performance

Shares of NYSE CAH opened at $158.50 on Friday. The stock has a market cap of $37.66 billion, a PE ratio of 24.57, a PEG ratio of 1.34 and a beta of 0.71. The business has a fifty day moving average of $152.12 and a two-hundred day moving average of $150.09. Cardinal Health, Inc. has a 52-week low of $106.98 and a 52-week high of $168.44.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings data on Tuesday, August 12th. The company reported $2.08 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.03 by $0.05. The company had revenue of $60.16 billion during the quarter, compared to analysts’ expectations of $60.91 billion. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The business’s revenue was up .5% on a year-over-year basis. During the same period last year, the business earned $1.84 earnings per share. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. Analysts predict that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 15th. Shareholders of record on Wednesday, October 1st will be issued a dividend of $0.5107 per share. The ex-dividend date of this dividend is Wednesday, October 1st. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.3%. Cardinal Health’s dividend payout ratio (DPR) is presently 31.63%.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.